The association of central obesity with type 2 diabetes among Koreans according to the serum gamma-glutamyltransferase level: Korean genome and epidemiology study

Journal of Preventive Medicine and Public Health

Volumn 42, Issue 6, 2009, Pages 386-391

  Shin, Ji Yeon ^a   Hwang, Jun Hyun ^a   Jeong, Jin Young ^b   Kim, Sung Hi ^c   Moon, Jai Dong ^d   Roh, Sang Chul ^e   Kim, Young Wook ^f   Kim, Yangho ^g   Leem, Jong Han ^h   Ju, Young Su ⁱ   Hong, Young Seoub ^j   Ha, Eun Hee ^k   Lee, Yong Hwan ^l   Lee, Duk Hee ^a   Kim, Dong Hyun ^b  

^a Kyungpook National University School of Medicine   (South Korea)

^b Hallym University College of Medicine   (South Korea)

^c Catholic University of Daegu   (South Korea)

^d Chonnam National University Medical School   (South Korea)

^e Dankook University   (South Korea)

^f Sungkyunkwan University School of Medicine   (South Korea)

^g University of Ulsan College of Medicine   (South Korea)

^h Inha University School of Medicine   (South Korea)

ⁱ Hallym University   (South Korea)

^j Dong A University College of Medicine   (South Korea)

^k Ewha Womans University School of Medicine   (South Korea)

^l Kosin University College of Medicine   (South Korea)

more..

Author keywords

Blood glucose; Gamma glutamyltransferase; Gender; Obesity; Type 2 diabetes mellitus

Indexed keywords

ADULT; ARTICLE; CORRELATION ANALYSIS; CROSS-SECTIONAL STUDY; FEMALE; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; GENETIC EPIDEMIOLOGY; HIGH RISK PATIENT; HUMAN; KOREA; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PATIENT IDENTIFICATION; PREVALENCE; RISK ASSESSMENT; SEX DIFFERENCE; WAIST HIP RATIO;

BLOOD GLUCOSE; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; EPIDEMIOLOGIC STUDIES; FEMALE; GAMMA-GLUTAMYLTRANSFERASE; HUMANS; MALE; MIDDLE AGED; OBESITY, ABDOMINAL; ODDS RATIO; PREVALENCE; REPUBLIC OF KOREA; WAIST-HIP RATIO;

EID: 77953658942     PISSN: 19758375     EISSN: None     Source Type: Journal    
DOI: 10.3961/jpmph.2009.42.6.386     Document Type: Article

References (28)

1. Brenner H, Rothenbacher D, Arndt V, Schuberth S, Fraisse E, Fliedner TM. Distribution, determinants, and prognostic value of gamma-glutamyltransferase for all-cause mortality in a cohort of construction workers from southern Germany. Prev Med 1997; 26(3): 305-310. (Pubitemid 27200465)
2. Nilssen O, Forde OH, Brenn T. The Tromso Study: Distribution and population determinants of gamma-glutamyltransferase. Am J Epidemiol 1990; 132(2): 318-326. (Pubitemid 20239356)
3. Lim JS, Kim YJ, Chun BY, Yang JH, Lee DH, Kam S. The association between serum GGT level within normal range and risk factors of cardiovascular diseases. J Prev Med Public Health 2005; 38(1): 101-106. (Korean)
4. Lee DH, Jacobs DR Jr, Gross M, Kiefe CI, Roseman J, Lewis CE, et al. Gamma-glutamyltransferase is a predictor of incident diabetes and hypertension: The Coronary Artery Risk Development in Young Adults (CARDIA) Study. Clin Chem 2003; 49(8): 1358-1366. (Pubitemid 36900623)
5. Lee DH, Ha MH, Kim JH, Christiani DC, Gross MD, Steffes M, et al. Gamma-glutamyl- transferase and diabetes: A 4 year follow-up study. Diabetobgia 2003; 46(3): 359-364. (Pubitemid 36547591)
6. Wannamethee G, Ebrahim S, Shaper AG. Gamma-glutamyltransferase: Determinants and association with mortality from ischemic heart disease and all causes. Am J Epidemiol 1995; 142(7): 699-708.
7. Perry IJ, Wannamethee SG, Shaper AG. Prospective study of serum gamma-glutamyltransferase and risk of NIDDM. Diabetes Care 1998; 21(5): 732-737.
8. Nannipieri M, Gonzales C, Baldi S, Posadas R, Williams K, Haffner SM, et al. Liver enzymes, the metabolic syndrome, and incident diabetes: The Mexico city diabetes study. Diabetes Care 2005; 28(7): 1757-1762. (Pubitemid 40923089)
9. Miura K, Nakagawa H, Nakamura H, Tabata M, Nagase H, Yoshida M, et al. Serum gamma-glutamyl transferase level in predicting hypertension among male drinkers. J Hum Hypertens 1994; 8(6): 445449. (Pubitemid 24195759)
10. Meisinger C, Lowel H, Heier M, Schneider A, Thorand B, KORA Study Group. Serum gamma-glutamyltransferase and risk of type 2 diabetes mellitus in men and women from the general population. J Intern Med 2005; 258(6): 527-535. (Pubitemid 41705393)
11. Ruttmann E, Brant LJ, Concin H, Diem G, Rapp K, Ulmer H, et al. Gamma-glutamyltransferase as a risk factor for cardiovascular disease mortality: An epidemiological investigation in a cohort of 163,944 Austrian adults. Circulation 2005; 112(14): 2130-2137. (Pubitemid 41475806)
12. Lee DH, Silventoinen K, Jacobs DR Jr, Jousilahti P, Tuomileto J. Gamma-glutamyltransferase, obesity, and the risk of type 2 diabetes: Observational cohort study among 20,158 middle-aged men and women. J Clin Endocrinol Metab 2004; 89(11): 5410-5414. (Pubitemid 39518418)
13. Andre P, Balkau B, Born C, Charles MA, Eschwege E, D.E.S.I.R. Study Group. Three-year increase of gamma-glutamyltransferase level and development of type 2 diabetes in middle-aged men and women: The D.E.S.I.R. cohort. Diabetologia 2006; 49(11): 2599-2603.
14. Jousilahti P, Rastenyte D, Tuomilehto J. Serum gamma-glutamyl transferase, self-reported alcohol drinking, and the risk of stroke. Stroke 2000; 31(8): 1851-1855. (Pubitemid 30620462)
15. Mensah GA, Mokdad AH, Ford E, Narayan KM, Giles WH, Vinicor F, et al. Obesity, metabolic syndrome, and type 2 diabetes: Emerging epidemics and their cardiovascular implications. Cardiol Clin 2004; 22(4): 485-504. (Pubitemid 39389004)
16. Ryu SH, Beck SH, Chang YS, Kim DI, Suh BS, Kim WS, et al. Abdominal obesity in relation to the incidence of type 2 diabetes mellitus and impaired fasting glucose among some Korean adults: A retrospective cohort study. J Prev Med Public Health 2004; 37(4): 359-365. (Korean)
17. Lim JS, Lee DH, Park JY, Jin SH, Jacobs DR Jr. A strong interaction between serum gamma-glutamyltransferase and obesity on the risk of prevalent type 2 diabetes: Results from the Third National Health and Nutrition Examination Survey. Clin Chem 2007; 53(6): 1092-1098.
18. Huxley R, Barzi F, Stolk R, Caterson I, Gill T, Lam TH, et al. Ethnic comparisons of obesity in the Asia-Pacific region: Protocol for a collaborative overview of cross-sectional studies. Obes Rev 2005; 6(3): 193-198. (Pubitemid 41032793)
19. Deurenberg P, Deurenberg-Yap M, Guricci S. Asians are different from Caucasians and from each other in their body mass index/body fat per cent relationship. Obes Rev 2002; 3(3): 141-146. (Pubitemid 34815232)
20. Kim DJ, Noh JH, Cho NH, Lee BW, Choi YH, Jung JH, et al. Serum gamma-glutamyltransferase within its normal concentration range is related to the presence of diabetes and cardiovascular risk factors. Diabet Med 2005; 22(9): 1134-1140.
21. Sabanayagam C, Shankar A, Li J, Pollard C, Ducatman A. Serum gamma-glutamyl transferase level and diabetes mellitus among US adults. Eur J Epidemiol 2009; 24(7): 369-373.
22. Zoppini G, Targher G, Trombetta M, Lippi G, Muggeo M. Relationship of serum gamma-glutamyltransferase to atherogenic dyslipidemia and glycemic control in type 2 diabetes. Obesity (Silver Spring) 2009; 17(2): 370-374.
23. Grundy SM. Gamma-glutamyl transferase: Another biomarker for metabolic syndrome and cardiovascular risk. Arterioscler Thromb Vasc Biol 2007; 27(1): 4-7. (Pubitemid 46360374)
24. Marchesini G, Brizi M, Bianchi G, Tomassetti S, Bugianesi E, Lenzi M, et al. Nonalcoholic fatty liver disease: A feature of the metabolic syndrome. Diabetes 2001; 50(8): 1844-1850. (Pubitemid 33641605)
25. Lee DH, Blomhoff R, Jacobs DR Jr. Is serum gamma glutamyltransferase a marker of oxidative stress? Free Radic Res 2004; 38(6): 535-539.
26. Shin JY, Kim YK, Park SG, Lee JN, Kim HC, Leem JH, et al. The clinical importance of an increase in serum-glutamyltransferase concentration. Korean J Occup Environ Med 2005; 17(1): 1-9. (Korean)
27. Lee DH, Jacobs DR Jr. Association between serum concentrations of persistent organic pollutants and gamma glutamyltransferase: Results from the National Health and Examination Survey 1999-2002. Clin Chem 2006; 52(9): 1825-1827.
28. Lee DH, Lee IK, Song K, Steffes M, Toscano W, Baker BA, et al. A strong dose-response relation between serum concentrations of persistent organic pollutants and diabetes: Results from the National Health and Examination Survey 1999-2002. Diabetes Care 2006; 29(7): 1638-1644.